China says it will decide on US tariff countermeasures in due course


By Colleen Howe and Liz Lee

BEIJING, Feb 24 (Reuters) – China is closely monitoring U.S. policies and will decide “in due course” whether to adjust ‌countermeasures to U.S. tariffs, a commerce ministry official said on Tuesday ‌after President Donald Trump said he would levy a new temporary tariff of 15% on U.S. imports ​from all countries.

China is willing to hold frank consultations during an upcoming sixth round of U.S.-China economic and trade talks, the commerce ministry official added.

“China has consistently opposed all forms of unilateral tariff measures and urges the U.S. side to cancel ‌unilateral tariffs and refrain from ⁠further imposing such tariffs,” the official said.

Trump’s latest announcement came after the Supreme Court on Friday struck down tariffs imposed under ⁠the International Emergency Economic Powers Act on goods shipped to the U.S.

Imports from China had been subject to 20% tariffs under the act.

Trump said after the decision that ​he ​would put a new 10% duty on ​U.S. imports from all countries, under ‌Section 122 of the Trade Act, then said in a Truth Social post later that he would raise it to 15%.

Other duties on Chinese goods under legislation known as Section 301 and Section 232 remain in place.

China had last year retaliated to Trump’s tariff war with multiple rounds of counter duties on American ‌goods, including targeted levies on agricultural commodities and ​in energy.

Beijing also leveraged its dominance in ​rare earths to restrict exports of ​highly sought after critical minerals.

China then suspended most of those ‌retaliatory measures in November after both ​countries reached a trade ​truce.

Trump plans to travel to China from March 31 to April 2 for highly anticipated talks with Chinese President Xi Jinping – a visit announced ​by the White House just ‌before the Supreme Court decision dealt a stinging blow to Trump’s ​global trade war.

(Reporting by Liz Lee, Colleen Howe and Beijing newsroom; ​Editing by Christian Schmollinger and Raju Gopalakrishnan)



Source link

  • Related Posts

    EMVision Medical Devices to Present at Australia Investor Day February 26th

    SYDNEY, Feb. 24, 2026 (GLOBE NEWSWIRE) — EMVision Medical Devices Limited (ASX:EMV), based in Sydney, Australia, focused on delivering novel diagnostic devices for stroke and traumatic brain injury patients, today announced that…

    Novo Nordisk to halve U.S. list price of Wegovy from 2027

    Novo Nordisk will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year, the Danish drugmaker said on Tuesday.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    EMVision Medical Devices to Present at Australia Investor Day February 26th

    AstraZeneca boss Pascal Soriot’s pay rises to £17.7m | AstraZeneca

    AstraZeneca boss Pascal Soriot’s pay rises to £17.7m | AstraZeneca

    Use These Expert Weightlifting Tips for a Fat-Burning and Toning Workout

    Use These Expert Weightlifting Tips for a Fat-Burning and Toning Workout

    18 Revolve Fashion and Beauty Items for a Chic Spring Break

    18 Revolve Fashion and Beauty Items for a Chic Spring Break

    Overton takes 'fabulous' catch to remove Salman

    Overton takes 'fabulous' catch to remove Salman

    Every Game Getting "Switch 2 Edition" Enhanced Versions

    Every Game Getting "Switch 2 Edition" Enhanced Versions